About Actome
Actome is a company based in Freiburg Im Breisgau (Germany) founded in 2016 by Attila Karsai. Actome offers products and services including PICO Kits, PICO Services, and PICOglue Antibody Labeling. Actome operates in a competitive market with competitors including Zephyr AI, Precisionlife, Chemify, Transaction Data Systems and RevolKa, among others.
- Headquarter Freiburg Im Breisgau, Germany
- Founders Attila Karsai
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Actome Gmbh
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
EIC Fund
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Actome
Actome offers a comprehensive portfolio of products and services, including PICO Kits, PICO Services, and PICOglue Antibody Labeling.
Kits for absolute protein quantification using digital PCR technology.
Custom antibody labeling and assay development for protein research.
Labeling technology for efficient antibody preparation in assays.
People of Actome
Unlock access to complete
Unlock access to complete
Funding Insights of Actome
Investors in Actome
Actome has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include EIC Fund and b.value.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Locked | Locked | Locked | |
|
b.value AG is focused on investing in DeepTech startups.
|
Locked | Locked | Locked |
Investor details for Actome
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Actome
Investment portfolio details for Actome
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Actome
Detailed financials for Actome
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Actome Comparisons
Peer comparison for Actome
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Actome
Actome operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Zephyr AI, Precisionlife, Chemify, Transaction Data Systems and RevolKa, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of AI development services for biopharma sector
|
|
| Locked | Locked | Locked |
AI-enabled platforms for drug discovery and precision medicine are developed.
|
|
| Locked | Locked | Locked |
Software development services are provided for pharmaceutical and materials research.
|
|
| Locked | Locked | Locked |
Software development services are provided to the biopharma sector.
|
|
| Locked | Locked | Locked |
AI development services are provided for the biopharma sector.
|
|
| Locked | Locked | Locked |
Drug discovery and design are enabled by a cloud-based platform.
|
Detailed competitors of Actome
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Actome
Complete news archive for Actome
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Actome
Actome was founded in 2016 and raised its 1st funding round 5 years after it was founded.
Actome is headquartered in Freiburg Im Breisgau, Germany. It is registered at Freiburg Im Breisgau, Baden-wurttemberg, Germany.
Csaba Jeney is the current CEO of Actome.
Actome was founded in 2016 as a provider of interactome technology focused on the biological quantification of proteins. Operations center on developing tools for analyzing protein interactions in the biotech sector. Leadership is provided by CEO Csaba Jeney and co-founder Attila Karsai. The companys domain indicates a base in Germany, with services aimed at research and quantification applications in biological sciences.
Actome offers PICO Kits, PICO Services, and PICOglue Antibody Labeling.